Fig. 1 · Structure
Documents & Downloads
LY 201409
Drug Derivative
LY 201409 is a drug derivative designed as an anticonvulsant compound that serves as an analog of LY-201116 with enhanced metabolic stability. This compound demonstrates the ability to antagonize seizures induced by maximal electroconvulsive shocks and exhibits mixed effects on seizures triggered by various chemoconvulsants. Additionally, LY 201409 influences behavioral and sleep patterns in murine models, making it a valuable tool in seizure research and neuropharmacological studies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 109306-94-7 |
| Applications | Drug Derivative |
| Formula | C17H20N2O |
| Molecular Weight | 268.35 |
| SMILES | O=C(C1=CC(C)=C(N)C(C)=C1)NC2=C(C)C=CC=C2C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.